Erschienen in:
17.03.2020 | Pancreatic Tumors
The Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection: Moving from Initial Adoption to Thoughtful Dissemination
verfasst von:
Daniel A. Anaya, MD, Ugwuji Maduekwe, MD, Jin He, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 6/2020
Einloggen, um Zugang zu erhalten
Excerpt
The International Consensus Conference on Minimally Invasive Pancreatic Surgery to review and vote on a final draft of guidelines on minimally invasive pancreas resection (MIPR) took place on 18–19 March 2019 in Miami. The Society of Surgical Oncology (SSO) provided sponsorship support of the meeting. The recent publication of the Miami International Evidence-Based Guidelines on Minimally Invasive Pancreas Resection indicated SSO endorsement of the guidelines. The MIPR guidelines were reviewed by three members of the SSO Hepato-Pancreato-Biliary Disease Site Working Group and three members of the SSO Quality Committee. Reviewers agreed the MIPR guidelines were well developed through the use of a validated methodology, the involvement of multiple stakeholders, and critical review by an audience of surgeons with an interest in pancreatic cancer. Although there are limitations in the data available to support the MIPR guidelines, reviewers felt this was acknowledged by authors, and their ‘call’ to the profession is to do better. Additionally, reviewers felt the potential impact of the guidelines is significant with respect to the creation of a framework to help guide the advancement and dissemination of novel surgical techniques without compromising the provision of safe, high-quality care. Based on the reviewer’s feedback and recommendations, the SSO leadership agreed that the Society endorse the guidelines. …
